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TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016Pro-inﬂammatory molecules; basic FGF, VEGF, PDGF-88, IL1, IL6,
TNF, IL17a, IL8, MCP1, IP10, MIP1, MIP1, Eotaxin, RANTES, IL2,
IL4, IL5, IL9,IL12, IL13, IL15, IFN, G-CSF, GM-CSF, IL7, IL10 were
measured in plasma by Milliplex 26-plex. Total RNA was isolated
from plasma and the proﬁle of miRs was determined by Real-time
quantitative RT-PCR analysis. We calculated an integrated index
using endothelial function, cytokine levels, and miR data, to look at
the relation between laboratory and clinical data following
treatment.
Results: Leukocyte and platelet counts, CRP and serum albumin
levels were similar before and after treatment. The groups did not
differ in eGFR, Ca, P, and 25-OH-vitamin D3 levels after treatment,
but there was a dose dependent response in PTH levels. Since the
number of patients was small, we merged both treatment groups (1
and 2 mg) for the analysis. VEGF, PDGF, Basic-FGF, Eotaxin, IL8,
IP10, MIP1 , IFN , IL9, IL12, IL7, IL17, G-CSF, and IL10 decreased
signiﬁcantly following the treatment, compared to placebo, as did
miR 432-5p, miR 495-3p, and miR 576-5p. The integrated index
showed a signiﬁcant relation between macro- and microvascular
endothelial function and microcirculation, with cytokines such as
basic-FGF, PDGF and VEGF, together with miR 432. In terms of miR
495, the integrated value showed signiﬁcance for microvascular
endothelial function.
Conclusions: Paricalcitol treatment in moderate CKD reduces
inﬂammation and levels of selected miRs, involved in the athero-
sclerosis process and platelet function. The decline in cytokines and
miRs could be linked to our previous clinical ﬁndings, using the
integrated index. This study suggests a role for VDRA in patients
with moderate CKD but further studies are warranted to more
deeply characterize the effects of vitamin D on immune and
endothelial cells, expression of cytokines and regulation of miRs in
the process of the disease
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Introduction: The relationship between microbiota-induced TH17
cells in the small intestine and pathogenic TH17 responses in
autoimmune diseases is still unclear.
Methods: Renal TH17 cells from patients with ANCA-associated
glomerulonephritis and nephritic mice using the nephrotoxic
nephritis model (NTN) were analyzed by ﬂow cytometry including
intracellular cytokine staining. Migration of T cells in nephritic
mice was analyzed using photoconvertible Kaede-transgenic mice.
Results: Here, we report high frequencies of CD4+RORgt+TH17
cells in the kidneys of patients with ANCA-associated crescentic
glomerulonephritis and in a mouse model of crescentic glomerulo-
nephritis. By labeling intestinal cells in photoconvertible Kaede-
transgenic mice, we were able to demonstrate that a signiﬁcant
proportion of the TH17 cells in the inﬂamed kidney originated from
the small intestine and inﬁltrated the kidney via the CCR6/CCL20
axis. In line, experiments in germ free mice and in mice treatedKidney International Reports (2016) 1, S1–S22with a cocktail of four antibiotics revealed that the TH17 response
in the kidney and the consecutive tissue injury in crescentic
glomerulonephritis depended on microbiota-induced intestinal
TH17 cells. Furthermore, in a therapeutic and well-tolerable
approach, treatment of mice with a single antibiotic (vancomycin)
signiﬁcantly reduced intestinal TH17 cells and subsequently renal
TH17 inﬁltration and tissue damage.
Conclusions: These ﬁndings identiﬁed a direct relationship be-
tween microbiota-induced TH17 cells and the destructive TH17
response in autoimmunity, suggesting that therapeutic manipula-
tion of the intestinal microbiota might provide new opportunities
for the treatment of TH17-driven autoimmune disorders.
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Introduction: Systemic and local immune responses of leukocytes
are important for host defense, but uncontrolled inﬂammation can
lead to various organopathy. In addition, once cross reaction has
formed between the external antigen and the autoantigen, various
autoimmune diseases and allergic diseases can be induced. PILR
expressed mainly on macrophages, dendritic cells and gran-
ulocytes, contains two immunoreceptor tyrosine-based inhibitory
motifs (ITIMs) in its cytoplasmic domain. PILR has described for its
negative regulatory functions for activation of leukocyte 2 integrin
in acute inﬂammation including LPS-induced endotoxin shock
model. Here, we investigated roles of PILR in antibody-mediated
glomerular inﬂammation.
Methods: Antibody-mediated glomerulonephritis was induced by
intravenous administration of nephrotoxic serum (NTS) after pre-
immunization with rabbit IgG in C57BL/6 (WT) and PILR -/- mice.
Functional analysis for renal injury was performed by urine albu-
min and serum creatinine (sCr) concentrations at day 7, 14 and 21.
Diseased kidneys from both mouse strains were harvested for his-
tology, renal leukocyte inﬁltrates by ﬂow cytometry and renal
cytokine proﬁles by ELISA after induction of glomerulonephritis.
In vitro, m2 integrin-dependent neutrophil adhesion on immune-
complex (IC) formed with BSA-anti BSA IgG was evaluated in both
mouse strains.
Results: PILR was speciﬁcally expressed on glomerular Ly6B+cells
(neutrophils and monocytes) in diseased WT mice. Similar amount
of pathogenic rabbit IgG deposition on GBM was observed in WT
and PILR -/- mice on day 14 kidney specimen, but BUN and sCr
concentrations were signiﬁcantly elevated in PILR -/- mice compare
to WT mice at day 14 and 21, and those were highly associated with
deteriorated proteinuria. In histological analysis, glomerular dam-
ages, corroborated with both glomerular PAS deposits and
glomerular crescent formation, were signiﬁcantly severe in PILR -/-
mice at day 14 and 21 (p<0.05). Moreover, glomerular neutrophil
accumulation was remarkably observed in PILR -/- mice compare to
WT mice. In addition, total inﬁltration of Ly6Ghigh neutrophils,
F4/80+ macrophages and CD3+CD4+ T cells in whole kidneys were
increased in PILR -/- mice than WT mice at day 14 and 21. Renal
proinﬂammatory cytokine proﬁles for IL-1 and IL-6 on day 21 also
demonstrated severe renal inﬂammation in PILR -/-mice. In vitro,S15
TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016PILR deﬁcient neutrophils showed enhanced adhesion and
spreading on IC compared to WT. IC adhesion-dependent H2O2
production of neutrophils was also increased in PILR -/- mice
compared to WT animals.
Conclusions: PILR deﬁciency resulted in deteriorated renal damage
in murine antibody-mediated glomerulonephritis compare to WT
mice. The present study indicated that PILR negatively regulates
antibody-mediated leukocyte recruitment by inhibition of m 2
integrin activation.
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Introduction: The immune system controls the gut microbiota.
Transplant recipients are treated with immunosuppressive (IS)
therapies which could impact host-microbial interactions. We
examined the impact of IS drugs on gut microbiota and on the
secretion of ileal antimicrobial peptides.
Methods: Mice were treated for 14 days with prednisolone,
mycophenolate mofetil, tacrolimus, a combination of these 3 drugs,
everolimus or water. Faeces were collected before and after treat-
ment initiation. Ileal samples were collected after sacriﬁce. Faecal
and ileal microbiota was analyzed by pyrosequencing of 16S rRNA
genes, and C-type lectins were assessed in ileal tissues by RT-qPCR.
Results: Prednisolone decreased Bacteroidetes and increased Fir-
micutes in the faeces. While prednisolone disrupted faecal micro-
bial community structure, no single OTU was consistently affected
in experimental replicates. In ileal samples, the genus Clostridia
sensu stricto was dramatically reduced in the prednisolone and
combined IS drug groups. These modiﬁcations corresponded to an
altered expression of C-type lectins, Reg3 and Reg3. Interestingly,
the combined IS treatment enabled a commensal Escherichia coli to
ﬂourish, and dramatically increased colonization by uropathogenic
E. coli strain 536.
Conclusions: IS treatment alters innate antimicrobial defenses and
disrupts the gut microbiota which leads to overgrowth of indige-
nous E. coli and facilitates colonization by opportunistic pathogens.
P34
DUAL BLOCKADE OF THE
HOMEOSTATIC CHEMOKINE CXCL12
AND THE PRO-INFLAMMATORY
CHEMOKINE CCL2 IS AS EFFECTIVE AS
CYCLOPHOSPHAMIDE IN
PROLIFERATIVE LUPUS NEPHRITIS
Devarapu, SK1, Kulkarni, OP2, Kumar, SV3, Eulberg, D4,
Anders, HJ3
1Klinikum der Universitaet Muenchen, Arbeitsgruppe Klinische Biochemie,
München, Germany; 2BITS Pilani, Department of Pharmacy, Hyderabad,S16India; 3Klinikum der Universität München, Nephrologisches Zentrum-Med-
izinische Klinik und Poliklinik IV, München, Germany; 4NOXXON Pharma
AG, NOXXON Pharma, Berlin, Germany
Introduction: Induction therapy of proliferative lupus nephritis
still requires the use of unselective immunosuppressive drugs with
signiﬁcant toxicities. More speciﬁc drugs with equal efﬁcacy but
fewer side effects are needed. In search of suitable molecular targets
we considered monocyte chemoattractant protein (MCP-1/CCL2)
and stromal cell-derived factor (SDF-1/CXCL12), which both
contribute to the onset and progression of proliferative lupus
nephritis yet through different mechanisms. We hypothesized that
dual antagonism of the homeostatic chemokine CXCL12 and the pro-
inﬂammatory chemokine CCL2 could be as potent on lupus
nephritis as the unselective and toxic immunosuppressant cyclo-
phosphamide (CYC).
Methods: We used l-enantiomeric RNA Spiegelmer chemokine
antagonists, i.e. the CCL2-speciﬁc mNOX-E36 and the CXCL12-
speciﬁc NOX-A12. Female MRLlpr/lpr mice were treated (subcu-
taneous injection) from week 12 to 24 of age of age either with
single regimen of anti-CXCL12 (13.4mg/kg) or anti-CCL2 (14.4 mg/
kg) or both along with standard regimen with cyclophosphamide
(CYC) (30mg/kg).
Tissues were harvested for histopathological evaluation at the
end of the treatment period. Blood and urine samples were obtained
at monthly intervals for the estimations of urinary albumin (ELISA:
Bethyl Labs, Montgomery, TX, USA) as well as serum and urinary
creatinine (Jaffé reaction: DiaSys Diagnostic Systems, Holzheim,
Germany). Inﬂammatory gene proﬁle was determined by RTPCR.
All experiments were performed according to German animal pro-
tection laws and had been approved by the local government
authorities.
Results: Dual blockade was signiﬁcantly more effective than
monotherapy in preventing proteinuria and BUN. Dual blockade
was also more effective in controlling the histopathological indices
of disease activity and chronicity. Dual blockade reduced IgG im-
munoglobulins, CD3+ lymphocytes and macrophages more efﬁ-
ciently than monotherapy. Dual blockade also reduced renal IL-6,
IL-12p40, CCL5, CCL-2 and CCR2 mRNA expression. Effects of dual
blockade on kidney functional parameters are at par with CYC
standard regimen.
Conclusions: Dual blockade of CCL2 and CXCL12 can be as potent
as CYC to suppress the progression of proliferative lupus nephritis
in female MRLlpr/lpr mice probably because the respective che-
mokine targets mediate different disease pathomechanisms, i.e.
systemic autoimmunity and peripheral tissue inﬂammation.
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Introduction: Lymphocytes occupy pivotal roles in immune-medi-
ated kidney diseases. However the respective contributions of
different lymphocyte subsets in diseased human kidneys are not
certain, with previous studies limited by the methodology of
immunohistochemistry to identify inﬁltrating cells.Kidney International Reports (2016) 1, S1–S22
